<SEC-DOCUMENT>0001104659-16-150423-index.html : 20161017
<SEC-HEADER>0001104659-16-150423.hdr.sgml : 20161017
<ACCEPTANCE-DATETIME>20161017095615
ACCESSION NUMBER:		0001104659-16-150423
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20161017
FILED AS OF DATE:		20161017
DATE AS OF CHANGE:		20161017

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics AG
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37558
		FILM NUMBER:		161938206

	BUSINESS ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
		BUSINESS PHONE:		43 (0)1 740 93-0

	MAIL ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a16-20032_16k.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: a16-20032_16k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a16-20032_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: a16-20032_1ex99d1.htm

</DOCUMENT>
</SEC-DOCUMENT>